The role of clinical pharmacology in optimizing antiretroviral therapy
Authors:
- 20 May 2003
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 55 (5) , 473-476
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patientsAIDS, 2002
- Critical Issues in Therapeutic Drug Monitoring of Antiretroviral DrugsTherapeutic Drug Monitoring, 2002
- Concentration-targeted therapy and the future of HIV managementAIDS, 2002
- Therapeutic drug monitoring in HIV infection: current status and future directionsAIDS, 2002
- Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyThe Lancet, 2002
- The pharmacogenomics of HIV therapyThe Pharmacogenomics Journal, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*SHuman Genetics, 1997